Approximately 6.5% of U.S. children — about 4.6 million — have childhood asthma, making it the most common chronic disease of childhood per the CDC. It is also the leading cause of school absenteeism due to chronic illness and one of the top reasons for pediatric ER visits. Asthma severity, control, and prognosis vary widely. Some children have mild intermittent symptoms with viral colds and outgrow much of the disease by adolescence. Others have moderate or severe persistent asthma that requires daily controller medications and ongoing specialist care. Modern asthma management — when followed — keeps the vast majority of children active, sleeping well, and out of the hospital.
What Asthma Is
Asthma is a chronic inflammatory disease of the airways, characterized by airway hyperresponsiveness, bronchoconstriction, and excess mucus production. The result is intermittent wheezing, cough, chest tightness, and shortness of breath. Asthma in children is often allergic in nature, particularly when it begins in early childhood and is associated with eczema and allergic rhinitis — the atopic march pattern.
The 2020 NAEPP focused updates and the GINA pediatric guidelines have shifted modern asthma care toward maintenance and reliever therapy approaches and away from rescue-only models, particularly for children 4 and older with moderate-to-severe disease.
Symptoms
Classic asthma symptoms include wheezing (a whistling sound during exhalation), cough that worsens at night or with exercise, shortness of breath with activity, chest tightness, and feeling unable to breathe deeply. In young children, cough may be the predominant or only symptom, and asthma can be missed when chronic cough is misattributed to recurrent bronchitis. Symptoms often worsen with viral upper respiratory infections, exercise, allergen exposure, cold air, or strong odors.
Severity is graded by symptom frequency: intermittent asthma has symptoms 2 or fewer days per week with rare nighttime awakenings; mild persistent has more than 2 days per week but not daily; moderate persistent has daily symptoms; severe persistent has continuous daytime symptoms with frequent nighttime awakenings.
Triggers
Common asthma triggers include viral respiratory infections (the leading trigger of acute exacerbations in children, especially RSV, rhinovirus, and influenza), allergens (dust mites, cockroach, mouse, pet dander, pollen, mold), exercise, cold and dry air, tobacco smoke and other irritants, air pollution, strong emotions or laughing hard, and certain foods and food additives in sensitized individuals. Some children’s asthma is triggered primarily by viruses and is largely silent between colds; others have year-round symptoms driven by allergens or exercise.
Identifying personal triggers is part of management. Allergy testing is recommended for moderate-to-severe persistent asthma, especially when symptoms are not well controlled.
Diagnosis
Asthma is diagnosed by combining history, physical exam, and objective testing. Spirometry — a breathing test measuring lung volumes and airflow — is the standard for children able to perform it (typically 5 years and older), and demonstrating reversible airflow obstruction (improvement after a bronchodilator) supports the diagnosis. In younger children, diagnosis is often presumptive based on recurrent wheezing patterns and response to a controller trial.
The Asthma Predictive Index helps estimate which preschoolers with recurrent wheezing are most likely to have persistent asthma. Other tests like fractional exhaled nitric oxide (FeNO) and methacholine challenge are used in selected cases. Per the NHLBI asthma guidelines, asthma diagnosis in young children is sometimes a clinical judgment that becomes clearer over time.
Treatment: Controllers, Relievers, and Action Plans
Asthma medications fall into two main categories. Controllers are taken daily to reduce airway inflammation and prevent symptoms. Inhaled corticosteroids (ICS) are first-line for persistent asthma — fluticasone, budesonide, mometasone, beclomethasone. Combination ICS/long-acting beta agonist (ICS/LABA) inhalers are added for moderate-to-severe persistent asthma. Leukotriene receptor antagonists (montelukast) are used in selected cases, with FDA black box warning about neuropsychiatric effects in 2020. Biologics — omalizumab, mepolizumab, dupilumab, benralizumab, tezepelumab — are options for severe asthma not controlled with conventional therapy.
Relievers (rescue inhalers) treat acute symptoms. Albuterol or levalbuterol via metered-dose inhaler with spacer is standard. The current GINA approach for older children and adolescents shifts toward as-needed ICS-formoterol rather than albuterol-only rescue, reducing both symptom burden and exacerbation risk.
Every child with persistent asthma should have a written Asthma Action Plan from their clinician, color-coded green/yellow/red zones based on symptoms and peak flow, with specific medication instructions for each zone. Action plans reduce ER visits and hospitalizations.
Inhaler Technique and Spacers
Improper inhaler use is one of the most common reasons “asthma medications don’t work.” Children under 5 should use a metered-dose inhaler with a valved holding chamber (spacer) and mask. Children 5 and older typically use a spacer with a mouthpiece. Dry powder inhalers require a sufficient inspiratory flow that many young children cannot generate, so they are usually reserved for older children. Have inhaler technique reviewed at every visit — even teenagers and parents make mistakes.
Asthma Attacks: Recognition and Initial Management
An asthma attack is an acute worsening of symptoms that requires increased medication. Early signs include increased cough, wheezing, decreased peak flow, and use of rescue inhaler more than usual. The Asthma Action Plan typically directs increased albuterol every 20 minutes for up to an hour, with oral steroids in some moderate exacerbations.
When to seek emergency care: Call 911 or go to the nearest emergency room if your child has signs of severe asthma exacerbation: tripod position (sitting forward, hands on knees), inability to speak in full sentences, severe retractions or use of neck muscles to breathe, fast breathing with grunting or nasal flaring, blue or gray lips, drowsiness or confusion, or no improvement after the first round of rescue inhaler. Status asthmaticus — severe, prolonged, treatment-resistant attack — is a medical emergency.
Prevention and Long-Term Management
Long-term asthma control depends on consistent controller use, trigger reduction, infection prevention, and regular follow-up. Annual influenza vaccination, COVID-19 vaccination per CDC schedule, and the routine childhood vaccine schedule help reduce exacerbations. RSV prevention in infancy with nirsevimab may reduce subsequent recurrent wheezing. Tobacco smoke exposure must be eliminated. Allergen reduction strategies — dust mite covers, pest control, pet dander mitigation — have modest evidence but help selected sensitized children.
Most children with mild asthma can participate fully in sports and physical activity with appropriate pre-exercise rescue inhaler use or controller optimization. Asthma is rarely a reason to limit activity, and physical fitness is generally protective.
Frequently Asked Questions
Will my child outgrow asthma?
Many children improve substantially in adolescence, particularly those with mild intermittent asthma triggered primarily by viral infections. Children with moderate-to-severe persistent asthma, atopic background (eczema, food allergies, allergic rhinitis), and ongoing allergen exposure are more likely to have persistent disease into adulthood.
Are inhaled steroids safe for kids?
Inhaled corticosteroids at recommended doses are well tolerated and safer than oral steroids. Modest, transient reductions in growth velocity can occur with high-dose ICS, but final adult height is typically minimally affected. Untreated persistent asthma is associated with worse long-term outcomes than appropriate ICS use.
What’s the difference between a controller and a rescue inhaler?
Controllers are taken daily (usually inhaled corticosteroids) to reduce inflammation and prevent symptoms. Rescue inhalers (albuterol) provide quick relief during acute symptoms. Reliance on the rescue inhaler more than 2 days per week, or refilling it more than twice a year, suggests undertreated asthma needing a controller.
When should my child see a pulmonologist or allergist?
Refer for: difficult-to-control asthma despite controller therapy, frequent exacerbations or hospitalizations, suspected aggravating allergies, complex medical comorbidities, consideration of biologics, or diagnostic uncertainty. Many primary care pediatricians manage mild asthma well without specialist input, but moderate-to-severe disease usually benefits from specialist involvement.
The Bottom Line on Childhood Asthma
Childhood asthma is common, treatable, and most children with it lead fully active lives. Consistent controller use, a written Asthma Action Plan, good inhaler technique, trigger reduction, and current vaccinations are the core of management. Pay attention to overuse of rescue inhalers — that signal almost always means controller therapy needs adjustment. Regular well-child visits include asthma assessment, and asthma fits within the broader cluster of atopic and respiratory pediatric conditions that includes eczema and allergies.